ATG5 and neoplasm: We found that the tumor volume and tumor weight in tumor-bearing Atg5flox/flox mice treated with an anti-CD8 antibody significantly increased, comparable to those in IgG-treated tumor-bearing Atg5+/+ mice, over IgG-treated tumor-bearing Atg5flox/flox mice (Figure 4J).